Christina M. Ferrer - Publications

Affiliations: 
2010-2015 Biochemistry Drexel University College of Medicine, Philadelphia, PA, United States 

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Linder SJ, Bernasocchi T, Martínez-Pastor B, Sullivan KD, Galbraith MD, Lewis CA, Ferrer CM, Boon R, Silveira GG, Cho HM, Vidoudez C, Shroff S, Oliveira-Costa JP, Ross KN, Massri R, et al. Inhibition of the proline metabolism rate-limiting enzyme P5CS allows proliferation of glutamine-restricted cancer cells. Nature Metabolism. PMID 37957387 DOI: 10.1038/s42255-023-00919-3  0.471
2022 Sebastian C, Ferrer C, Serra M, Choi JE, Ducano N, Mira A, Shah MS, Stopka SA, Perciaccante AJ, Isella C, Moya-Rull D, Vara-Messler M, Giordano S, Maldi E, Desai N, et al. A non-dividing cell population with high pyruvate dehydrogenase kinase activity regulates metabolic heterogeneity and tumorigenesis in the intestine. Nature Communications. 13: 1503. PMID 35314684 DOI: 10.1038/s41467-022-29085-y  0.441
2022 Ciraku L, Bacigalupa ZA, Ju J, Moeller RA, Le Minh G, Lee RH, Smith MD, Ferrer CM, Trefely S, Izzo LT, Doan MT, Gocal WA, D'Agostino L, Shi W, Jackson JG, et al. O-GlcNAc transferase regulates glioblastoma acetate metabolism via regulation of CDK5-dependent ACSS2 phosphorylation. Oncogene. PMID 35190642 DOI: 10.1038/s41388-022-02237-6  0.809
2021 Choi JE, Sebastian C, Ferrer CM, Lewis CA, Sade-Feldman M, LaSalle T, Gonye A, Lopez BGC, Abdelmoula WM, Regan MS, Cetinbas M, Pascual G, Wojtkiewicz GR, Silveira GG, Boon R, et al. A unique subset of glycolytic tumour-propagating cells drives squamous cell carcinoma. Nature Metabolism. 3: 182-195. PMID 33619381 DOI: 10.1038/s42255-021-00350-6  0.34
2019 Chang AR, Ferrer CM, Mostoslavsky R. SIRT6, a Mammalian deacylase with multitasking abilities. Physiological Reviews. PMID 31437090 DOI: 10.1152/Physrev.00030.2018  0.42
2019 Etchegaray JP, Zhong L, Li C, Henriques T, Ablondi E, Nakadai T, Van Rechem C, Ferrer C, Ross KN, Choi JE, Samarakkody A, Ji F, Chang A, Sadreyev RI, Ramaswamy S, et al. The Histone Deacetylase SIRT6 Restrains Transcription Elongation via Promoter-Proximal Pausing. Molecular Cell. PMID 31399344 DOI: 10.1016/J.Molcel.2019.06.034  0.317
2017 Sodi VL, Bacigalupa ZA, Ferrer CM, Lee JV, Gocal WA, Mukhopadhyay D, Wellen KE, Ivan M, Reginato MJ. Nutrient sensor O-GlcNAc transferase controls cancer lipid metabolism via SREBP-1 regulation. Oncogene. PMID 29059153 DOI: 10.1038/Onc.2017.395  0.777
2017 Beatty A, Fink LS, Singh T, Strigun A, Peter E, Ferrer CM, Nicolas E, Cai KQ, Moran TP, Reginato MJ, Rennefahrt U, Peterson JR. Metabolite profiling reveals the glutathione biosynthetic pathway as a therapeutic target in triple negative breast cancer. Molecular Cancer Therapeutics. PMID 29021292 DOI: 10.1158/1535-7163.Mct-17-0407  0.755
2016 Ferrer CM, Lu TY, Bacigalupa ZA, Katsetos CD, Sinclair DA, Reginato MJ. O-GlcNAcylation regulates breast cancer metastasis via SIRT1 modulation of FOXM1 pathway. Oncogene. PMID 27345396 DOI: 10.1038/Onc.2016.228  0.837
2016 Ferrer CM, Sodi VL, Reginato MJ. O-GlcNAcylation in Cancer Biology: Linking Metabolism and Signaling. Journal of Molecular Biology. PMID 27343361 DOI: 10.1016/J.Jmb.2016.05.028  0.84
2015 Ferrer CM, Reginato MJ. Sweet connections: O-GlcNAcylation links cancer cell metabolism and survival. Molecular & Cellular Oncology. 2: e961809. PMID 27308381 DOI: 10.4161/23723548.2014.961809  0.851
2015 Ferrer CM. Abstract 518: O-GlcNAcylation regulates breast cancer cell invasion via the NAD+-dependent deacetylase SIRT1 Cancer Research. 75: 518-518. DOI: 10.1158/1538-7445.Am2015-518  0.75
2015 Sodi VL, Bacigalupa Z, Ferrer C, Reginato M. Abstract 1194: O-GlcNAcylation regulates breast cancer lipid metabolism via sterol regulatory element binding protein 1 Cancer Research. 75: 1194-1194. DOI: 10.1158/1538-7445.Am2015-1194  0.776
2014 Ferrer CM, Reginato MJ. Cancer metabolism: cross talk between signaling and O-GlcNAcylation. Methods in Molecular Biology (Clifton, N.J.). 1176: 73-88. PMID 25030920 DOI: 10.1007/978-1-4939-0992-6_7  0.832
2014 Ferrer CM, Lynch TP, Sodi VL, Falcone JN, Schwab LP, Peacock DL, Vocadlo DJ, Seagroves TN, Reginato MJ. O-GlcNAcylation regulates cancer metabolism and survival stress signaling via regulation of the HIF-1 pathway. Molecular Cell. 54: 820-31. PMID 24857547 DOI: 10.1016/J.Molcel.2014.04.026  0.816
2014 Ferrer CM, Reginato MJ. Sticking to sugars at the metastatic site: sialyltransferase ST6GalNAc2 acts as a breast cancer metastasis suppressor. Cancer Discovery. 4: 275-7. PMID 24596201 DOI: 10.1158/2159-8290.Cd-14-0075  0.771
2012 Lynch TP, Ferrer CM, Jackson SR, Shahriari KS, Vosseller K, Reginato MJ. Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis. The Journal of Biological Chemistry. 287: 11070-81. PMID 22275356 DOI: 10.1074/Jbc.M111.302547  0.854
2011 Lynch TP, Jackson SR, Shahriari KS, Ferrer CM, Lazarus M, Walker S, Vosseller K, Reginato MJ. Abstract 1267: Metabolic sensor O-GlcNAc Transferase is a novel regulator of prostate cancer invasion and angiogenesis via regulation of FoxM1 Cancer Research. 71: 1267-1267. DOI: 10.1158/1538-7445.Am2011-1267  0.833
Show low-probability matches.